Seymour, MT (2011) Sequential Chemotherapy for Colorectal Cancer. Lancet Oncology, 12. 1 - 2 (2). ISSN 0140-6736
Abstract
In The Lancet Oncology, Michel Ducreux and colleagues1 present data that—not for the first time—challenge the assumption that patients with incurable metastatic colorectal cancer should always receive the most active regimen available as first-line treatment.
Metadata
| Authors/Creators: |
|
|---|---|
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Oncology and Clinical Research (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 19 Sep 2011 10:06 |
| Last Modified: | 04 Nov 2016 03:10 |
| Published Version: | http://dx.doi.org/10.1016/S1470-2045(11)70233-9 |
| Status: | Published |
| Publisher: | Elsevier |
| Identification Number: | https://doi.org/10.1016/S1470-2045(11)70233-9 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)